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We have demonstrated that transplantation
of the autologous cervical sympathetic ganglion
into the brain ameliorated MPTP-induced
parkinsonism in the monkey. According to the
encouraging data from this animal model, we
have applied this transplantation method to
parkinsonian patients. Eight patients (45 59
years, 5 male and 3 female) underwent stereo-
tactic transplantation of the aUtologous stellate
ganglion into the unilateral caudate nucleus and
putamen. Under local anesthesia a stereotactic
frame was fixed to the patient’s head, and the
frame and patient’s brain were simultaneously
imaged to obtain the coordinates of the target
points. Then the stellate ganglion was removed
and cut into 100 pieces in a tissue culture solu-
tion. The small blocks of the ganglion were
stereotaxically transplanted into the head of the
caudate nucleus and anterior putamen. One
week before transplantation, administration of
L-dopa was stopped in all 8 patients. Pre- and
postoperative states of the patients were care-
fully observed by a neurologist and were scored
using the unified parkinsonism rating scale
(UPRS), Hoehn & Yahr’s stage and four timed
tests. Postoperative courses of the patients were
encouraging. Seven out of 8 patients showed
amelioration of parkinsonism, but one patient
did not. Most patients showed amelioration of
gait disturbance and bradykinesia. In contrast,
tremor of the 7 patients seemed to be slightly
aggravated 2 4 weeks after transplantation. No
L-dopa administration was needed in these
patients. During follow-up periods from 2
months to 1 year, the seven patients showed
gradual and continuous improvement of parkin-
sonian symptoms, especially gait disturbance and
bradykinesia. Unilateral transplantation resulted
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in bilateral improvement of bradykinesia as
judged from the results of four timed tests. One
patient showed no improvement of the symp-
toms and needed L-dopa treatment even after
the operation. In this case, the preoperative
patient’s state was severe (4- 5 in Yahr’s stage),
and catecholamine cells in the stellate ganglion
observed under histofluorescence were severely
damaged. Also a small hemorrhage was ob-
served in the transplanted site under post-
operative CT scan. As complications of this
surgery, all patients revealed Horner’s syndrome
such as ptosis and miosis of the eye on the
stellate ganglion operation side.
These clinical data suggest that the autolo-
gous cervical sympathetic ganglion can be a
donor tissue for neural transplantation in
Parkinson’s disease.
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